WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tonix Pharmaceuticals Holding earnings were -$131.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest TNXP earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$16.8M, down 23.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNXP reported annual earnings of -$130.0M, with 11.5% growth.

TNXP earnings history

Current Revenue
$10.0M
Current Earnings
-$131.9M
Current Profit Margin
-1,313.9%

TNXP Return on Equity

Current Company
-121%
Current Industry
-60.2%
Current Market
31.5%
TNXP's Return on Equity (-121%)... subscribe to Premium to read more.
High Return on Equity Performance

TNXP undefined

Current Company
-101.3%
Current Industry
-2.5%
TNXP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TNXP announces earnings.

TNXP undefined

Current Company
-73%
Current Industry
5.8%
TNXP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TNXP vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TNXP-$129.22M-$131.93MN/A-$1,664.44
AARDN/AN/AN/AN/A
TVRD-$35.47M-$45.08MN/A-$30.01
TVGN-$31.43M-$31.90MN/A-$0.20
FHTX-$71.61M-$80.44MN/A-$1.36
View Top Biotech Stocks

Tonix Pharmaceuticals Holding Earnings Reports & History FAQ

What were Tonix Pharmaceuticals Holding's earnings last quarter?

On TNXP's earnings call on Invalid Date, Tonix Pharmaceuticals Holding (NASDAQ: TNXP) reported Q1 2025 earnings per share (EPS) of -$2.84, up 99.47% year over year. Total TNXP earnings for the quarter were -$16.83 million. In the same quarter last year, Tonix Pharmaceuticals Holding's earnings per share (EPS) was -$535.72.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.

Is Tonix Pharmaceuticals Holding profitable or losing money?

As of the last Tonix Pharmaceuticals Holding earnings report, Tonix Pharmaceuticals Holding is currently losing money. Tonix Pharmaceuticals Holding's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$131.93 million, a 33.81% increase year over year.

What was TNXP's earnings growth in the past year?

As of Tonix Pharmaceuticals Holding's earnings date in Invalid Date, Tonix Pharmaceuticals Holding's earnings has grown year over year. TNXP earnings in the past year totalled -$131.93 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.